CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer.

Li M, Li S, Zhao R, Lv J, Zheng D, Qin L, Li S, Wu Q, Long Y, Tang Z, et al. CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer. Clin Exp Med. 2022.